Market Demand Sample Clauses

Market Demand. The economic and technical capacity of markets to use recyclable material to make new products.

Market Demand. The Licensee shall use its best efforts to promote sales of the Licensed Products throughout the Territory and to satisfy market demand for the Licensed Products in the Territory. The Licensee shall maintain such inventory of the Licensed Products as may be necessary to meet its customers’ requirements.

Market Demand. Definition: the demand for customized products in the market sector addressed by the company and the ability to intercept this demand • Why this is required: the existence of unsatisfied customer needs for customized and personalized solutions is essential in order to undergo the business model. Moreover the company has to be able to understand the actual and future market requirement in order to adapt is value proposition. In MC it is in fact critical to capture new needs and trend thus enabling the provision of innovative, personalized products to new market niches. Moreover, customers must be able to understand the value of customization in order to appreciate and choose the provided solutions. At the same time also companies have to properly assess and evaluate the added cost of the customization to define the right price.

Market Demand. (a) Clear English is increasingly being used in the business and legal worlds: • The Plain English Campaign has resulted in a substantial increase in the preparation of plain English documents by, for example, banks and insurers for their retail and consumer businesses (including a number of our clients). • The Unfair Terms in Consumer Contracts Regulations 1999 require consumer contracts to be written in plain and intelligible language and to be accessible in design and layout. If there is any doubt over the meaning of a consumer contract it is interpreted in the way which is most favourable to the consumer. • The Office of Fair Trading promotes changes in unclear terms in consumer contracts and the removal of unnecessary or pointless language. Similar requirements apply throughout the EU. • The Civil Procedure Rules encourage the use of plain English in drafting statements of case (which used to be called "pleadings"). • The European Parliament, Commission and Council adopted an Inter-institutional Agreement in 1998. This provides that Community legislative acts must be drafted "clearly, simply and precisely".

Market Demand. Although North Americans comprise only 4% of the worldwide share of people living with HIV, they hold a 41% share of the global HIV therapeutics market.[15] Even then, as shown in Figure 1, only 30% of HIV-infected patients are considered virally suppressed.[3] About 48,000 new cases of HIV are diagnosed every year in North America, however new cases of HIV- positive children have declined to below 200 in 2012. ARV drugs for pregnant women and early infant prophylaxis have contributed to this progress.[15] With the new WHO guidelines, the number of eligible ARV patients has greatly increased. Coupled with the technological advances and accessibility of the HIV diagnostics market, the high costs of HIV drugs and the increase in life expectancy for HIV-positive patients have contributed to the continuous growth in the overall market size throughout the years. The lack of competition, however, suggests that supply is more limiting than the demand for HIV treatment. Although demand for HIV therapeutics continues to rise in the United States, the market is expected to experience a compound annual growth rate (CAGR) of -2.1%, representing a $7.6 billion market in 2013 dropping to $6.8 billion in 2018. From 2017 onwards, the decline will largely be due to the patent expiration of Xxxxxxx’x Prezista (darunavir) and Xxxxxxx-Xxxxx Squibb’s Reyataz (atazanavir). Due to the patenting of new formulations of STR FDC drugs which can combine these drugs in novel, synergistic methods, demand would have to shift to new treatments for companies to continue to profit.[15] The market has been seeing a major decline in the shares of the top eight leading drugs in 2012 (Table 2). First, the original eight leads are being replaced by newer, more potent, and less toxic drugs like Stribild, Complera, and Trivicay. Second, the generic drug market has been expanding, as shown in the Others category, as many of the former leads lose their patents. Although newer drugs and formulations are becoming more clinically popular, the presence of generic, cheaper options may alter insurance policies. STR FDC drugs are also more cost effective than paying for individual component drugs. Therefore, although the accessibility of treatment may increase in terms of cost and newer drugs will offset some lost revenue from the shift to generics, there is still projected to be a decline in the overall market by 2018.